$BIIB

$230.50▲ +2.1% YTD

4 SEC 13D/G filings tracked · Last updated Oct 12, 2026

Filing History

News

BIIB ▲ +2.1% - Biogen Inc.

CP $230.50▲ +2.1%Oct 12, 2026 · ThinkSabio Blog

$BIIB u/g Overweight @ JPM pt 300 from 210…

News

BIIB ▼ -0.8% - Biogen Inc.

CP $221.16▲ -0.8%Oct 2, 2026 · ThinkSabio Blog

$BIIB - Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing It…

News

BIIB ▲ +1.5% - Biogen Inc.

CP $219.05▲ +1.5%Sep 17, 2026 · ThinkSabio Blog

$BIIB - Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabiliz…

SEC 13D/G

BIIB - Biogen Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$203.13▲ 14.26%Aug 6, 2026 · ThinkSabio Blog

$BIIB SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #BIIB Biogen Inc. : $203.13 Sector: Healthcare | YTD: 🔼+ 14.26%…